Two cellular proteins, membrane cofactor protein (MCP) and moesin, were reported recently to be functionally associated with the initiation of a measles virus infection. We bave analyzed the interaction of measles virus with cell surface proteins, using an overlay binding assay with cellular proteins immobilized on nitrocellulose. Among surface-biotinylated proteins from a human rectal tumor cellline (HRT), measles virus, was able to bind only to a 67-kDa proteinthat was identified as MCP. The virus recognized dift'erent isoforms of MCP expressed from human (HRT and HeLa) and simian (Vero) celllines. The binding of measles virus to MCP was abolished after cleavage of the disulfide bonds by reducing agents as weil as after enzymatic release of N-linked oligosaccharides. By contrast, removal of sialic acid or 0-linked oligosaccharides did not aft'ect the recognition of MCP by measles virus. These data indicate that the receptor determinant of MCP is dependent on a conformation of the protein that is maintained by disulfide bonds and N-glycans present in tbe complement binding domains. Our results are consistent with a roJe of MCP as primary attacbment site for measles virus in the initial stage of an infection. The functional relationship between MCP and moesin in a measles virus infection is discussed.
Measles virus (MV) is an enveloped negative-strand RNA virus that contains two surface glycoproteins: the hemagglutinin (H), responsible for attachment to cells as weil as for agglutination of erythrocytes, and the fusion protein (F). The entry of MV occurs by binding to specific protein receptors on the host cell and subsequent fusion of the viral with the plasma membrane, resulting in the release of the nucleocapsid into the cytoplasm (for a review, see reference 5).
MV shows a very restricted host range: humans are the only naturally infected species. For the propagation of the virus in cell culture, human or simian cells can be used. Lack of suitable receptors may be responsible for the resistance of many cells from species other than higher primates, although MV can be adapted to cells of many species, with replication continuing on low Ievels. For many years the cellular counterparts in the binding reaction have remained elusive, although several studies have suggested some receptor candidates. The substance P receptor has been reported to promote the fusion activity of MV (13) . Proteins of 20 and 35.5 kDa that were isolated from membranes of Vero cells and African green monkey erythrocytes were able to inhibit virus attachment, infectivity, and hemagglutination activity, but they have not been characterized further (15) . Recently, conclusive evidence was presented that membrane cofactor protein (MCP; also designated CD46) is an MV receptor (11, 22, 25) . After transfection of nonpermissive cells (mouse or hamster) with MCP cDNA, MV was able to infect these cells. MCP is a C3-binding membrane protein and inhibits complement activation on host cells. lt is widely expressed on human cells examined but is absent from erythrocytes. Alternative splicing gives rise to different MCP isoformsthat di:ffer in both amino acid sequence and glycosylation (for a review, see reference 21 ) . In a recent report, another membrane protein, moesin, has been shown to be also linked with susceptibility of cells to MV infection (12) . Moesin, a membrane-organizing extension spike protein, is largely localized at the inner side of the plasma membrane but also accessible to antibodies on the cell surface (12, 18) . Treatment of cells with antibodies to moesin reduces the proliferation rate of smooth muscle cells (17) . As described for MCP (27) , moesin was found tobe downregulated on cells persistently infected with MV (12) . Aßtibodies to both proteins, CD46 as weil as moesin, inhibit the infection of cells with MV (12, 25) .
With the increasing information about virus receptors, it has become obvious for several viruses that more than one cellular surface component may be involved in the initial interaction between a virus and a cell. Evidence for this concept has been presented for human immunodeficiency virus (6, 8, 10, 14) and poliovirus (24, 31) . To understand the molecular events during this early stage of infection, it is important to determine whether a proposed receptor is involved in the attachment of the virus to the cell or in the subsequent fusion reaction between the viral and cellular membrane. lf a receptor is required for virus binding, it has to be established whether this molecule directly interacts with the virus or whether it assists another surface component in accomplishing the attachment of the virion to the plasma membrane. 6299 We have started to analyze the interaction of MV with cellular receptors (MCP and moesin) by establishing an in vitro binding assay. Here we show that MV can bind to MCP immobilized on nitrocellulose. We present evidence that disulfide bonds and glycosylation are critical for maintaining a conformation of MCP that is recognized by MV.
(This work was done in partial fulfillment of the requirements for the degree Dr.rer.physiol. for A.M., Fachbereich Humanmedizin, Philipps-Universität Marburg.)
MATERIALS AND METHODS
Cells and virus. HRT (human rectal tumor), HeLa (human cervical carcinoma), and Vero (African green monkey kidney) cells were propagated in Dulbecco's modified Eagle's minimal essential medium supplemented with 10% fetal calf serum. The Edmonston strain of MV was grown in Vero cells. Virus was harvested from the supernatant when 50 to 80% of the cells showed a cytopathic eft'ect. After clarification of the medium by low-speed centrifugation (3,000 X g, 20 min), virus was sedimented by ultracentrifugation at 100,000 X g for 90 min. The pellet was suspended in phosphate-buft'ered saline (PBS) and again pelleted at 150,000 X g for 35 min. After resuspension in PBS, the partially purified virus concentrate was stored at -80°C.
Preparation of biotinylated MV glycoproteins. Freshly prepared virus concentrate was labeled with sulfosuccinimidobiotin (S-NHS-biotin; Pierce) by a modification of the protocol described by Clayson et al. (9) . Virus samples containing 1 mg of viral protein in 1 ml of PBS were added to 0.66 ml of S-NHS-biotin dissolved in dimethyl sulfoxide (120 J.Lg/ml) and incubated for 4 h at room temperature. After dilution with PBS, biotinylated virus was sedimented by ultracentrifugation (150,000 X g, 35 min). Following the biotinylation of virus, the viral glycoproteins were isolated. Biotinylated virus suspended in 800 J.LI of PBS was incubated in the presence of 5% n-octylglucopyranoside (Sigma) for 10 min at room temperature. After centrifugation for 10 min at 12,000 X g, the supernatant was further incubated for 20 min at 4°C. Following centrifugation for 30 min at 100,000 x g, the supernatant was layered on a sucrose gradient (5 to 30% [wt/wt] on a cushion of 60% sucrose) in PBS containing 1% octylglycoside. After centrifugation for 17 h at 200,000 X g in an ·SW55.1 rotor (Beckman), fractions of 0.5 ml were collected from the bottom of the tube. The samples were analyzed by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE). To determine the fraction containing the MV glycoproteins, the gel was stained with Coomassie brilliant blue. To check the biotinylation, the polyacrylamide gel was blotted to nitrocellulose and the biotinylated proteins were detected by incubation with streptavidin-biotinylated horseradish peroxidase complex (1 h) followed by an incubation with PBS-4-chloro-1-naphthol-H202 (500:100:1). The fractions used for the glycoprotein overlay protein binding assays (GOBPA) consisted predominantly of MV H protein.
Isolation of biotinylated cell surface proteins. Cell surface proteins were labeled as described by Lisanti et al. (20) . After repeated washings with ice-cold PBS containing 0.1 mM CaCI 2 and 1 mM MgC1 2 (PBS-C/M), cells were incubated twice with S-NHS-biotin in PBS-C/M (0.5 mglml) for 30 min at 4°C. After the treatment, the cells were washed once with PBS containing 0.1 M glycine and four times with PBS. The cells were seraperl from the culture fl.ask into a solution of PBS containing 1 mM EDTA. After Iysis of the cells with radioimmunoprecipitation assay (RIPA) buffer (1% Triton, 1% sodium deoxycholate, 0.1% SOS, 0.15 M NaCI, 10 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 10 mM iodoacetamide, 0.14 mg of aprotinin per ml, 20 mM Tris-HCI [pH 7.5]), the biotinylated proteins were precipitated by addition of 50 J.Ll of packed streptavidinagarose (Pierce ). Following an incubation for 2 h on ice, the precipitates were washed and eluted by boiling in electrophoresis sample buffer lacking mercaptoethanol. The proteins J. VIROL. were separated on an SDS-12% polyacrylamide gel under reducing or nonreducing conditions. Mter SDS-PAGE, the proteins were blotted to a nitrocellulose sheet. As described for the biotinylated MV glycoproteins, the biotinylated cell proteins were detected by incubation with streptavidin-biotinylated horseradish peroxidase complex and peroxidase substrate.
Immunoprecipitation of MCP. Unlabeled or surface-biotinylated cells were lysed with RIP A buffer, and immunoprecipitation was carried out with a monoclonal antibody (MAb) directed against MCP: J4/48 (Dianova), GB24 (1), or TRA2-10 (2). After an incubation for 2 h on ice, the mouse immunoglobulins were precipitated by addition of 50 J.Ll of protein A-Sepharose (Sigma) preincubated with rabbit anti-mouse immunoglobulins. The precipitates were washed and either used for glycosidase treatments or, after boiling in sample buffer, subjected to SOS-PAGE. The proteins were separated on an SDS-12% polyacrylamide gel under nonreducing conditions and blotted to nitrocellulose.
Glycosidase treatments. For the removal of sialic acid, MCP bound toprotein A-Sepharose was incubated for 2 hat 37°C with 250 mU of neuraminidase from Vibrio cholerae (VCNA;
Behring, Marburg, Germany). For the treatment with other glycosidases, MCP was eluted from the beads by heating at 96°C in a 50 mM phosphate buffer (pH 7.0) containing 0.1% SDS. To release the N-linked oligosaccharides, the eluate was digested overnight with 1 U of N-glycosidase F (Boehringer, Mannheim, Germany) at 37°C. For the removal of 0-linked oligosaccharides, the eluate containing VCNA-treated MCP was incubated for 18 hat 37°C with 5.6 mU of 0-glycosidase (endo-a-N-acetylgalactosaminidase; Boehringer). Prior to SOS-PAGE, the digested samples were boiled at 96°C for 5 min in sample buffer (0.1 M Tris-HCI [pH 6.8], 10% glycerol, 2% SDS) and electrophoresed in 12% polyacrylamide gels. After blotting to nitrocellulose, the digested proteins were analyzed byGOPBA.
Binding assays. Binding of MV to proteins blotted to nitrocellulose was analyzed by a virus overlay protein binding assay (VOPBA) (7) or by a modified GOPBA with biotinylated MV glycoproteins. Prior to the binding assay, the nitrocellulose sheet was kept in a solution of 10% nonfat dry milk in phosphate-buft'ered saline (PBS) overnight at 4°C. Following three washes with PBS containing 0.1% Tween, the nitrocellulose was incubated for 45 min at 4°C with 5 to 10 1-Lg of partially purified MV in 400 J.Ll of PBS-Tween (VOPBA) or with 10 ~g of biotinylated glycoproteins in PBS (GOPBA). In the VOPBA, bound MV was detected, after washing with PBS-Tween, with MAb K83 directed to the MV H protein (19) diluted 1:100 in PBS-Tween. After washing, the blot was incubated with horseradish peroxidase (POX)-conjugated anti-mouse immunoglobulins ( anti-mouse/POX) from rabbit (dilution 1:400 in PBS-Tween). In the GOPBA, the bound biotinylated glycoproteins were detected with streptavidinbiotinylated POX (streptavidin/POX) complex (dilution 1:500 in PBS-Tween). All incubation and washing steps were performed at 4°C. The proteins recognized by MV or MV glycoproteins were stained by the detection of the bound POX by using the enhanced chemiluminescence system (ECL; Amersham). The resulting lightemissionwas visualized by exposure of the nitrocellulose to an autoradiography film (Hyperfilm ECL; Amersham ).
Western immunoblotting. The semidry Western blot method (16) was performed by the modification described by Schultze et al. (30) . MAb J4/48 (Dianova) at a dilution of 1:50 in PBS-Tween was used to detect MCP on nitrocellulose sheets. After incubation with anti-mouse/POX, the protein was visualized by ECL.
RESULTS
Binding of MV to a 67-:kDa surface protein from IIRT cells.
We attempted to detect the direct binding of MV to cell surface proteins by using a VOPBA After surface biotinylation and Iysis of HRT cells, the cellular proteins were separated by SDS-PAGE and blotted to nitrocellulose. The immobilized proteins. were used for a binding assay with MV (Fig.  lA) and for a Western blot with J4/48 (Fig. lB) . H the cell lysate was directly analyzed, no specific binding of MV to any cellular protein could be detected (Fig. 1A, lane 1) . However, if the biotinylated proteins were isolated with stt:eptavidinagarose, and thereby concentrated, a protein of 67 kDa wa8 recognized (lane 2). As shown in Fig. 1B , J4/48 reacted with a protein of the same size, suggesting that virus and antibody bind both to the same protein. The antibody even recognized a weak band in the cell lysate (lane 1 ), indicating that the Western blQt ha8 a higher sensitivity than the VOPBA.
As a control, surface proteins from a nonhuman cell line (Madin-Darby canine kidney cells) were isolated and also analyzed, but neither MV nor the MAb recognized any proteiri (data not shown).
Binding .of MV and isolated glycoproteins to immunoprecipitated MCP. To ensure that the 67-kDa protein recognized in the VOi'BA was indeed MCP, the proteinwas immunoprecipitated from HRT celllysates with J4/48. After SDS-PAGE under nonreducing conditions and blotting to nitrocellulose, MCP was detected bothin a Western blot with J4/48 (Fig. 2 , lane 2) and in a VOPBA with MV (Fig. 2, lane 3) . In cantrast to the binding assay with HRT cell surface proteins (Fig. 1) , the ass~y with immunoprecipitated MCP shows binding to both iritracellular and surface MCP (Fig. 2) . The lower bandsthat were stained in af:ldition to the 67-kDa protein probably represent intracellular, incompletely processed forms of MCP.
To determine whether the binding to MCP could also be detected with solubilized viral glycoprotein, a preparation of biotin-labeled MV glycoproteins containing predominantly H protein was used for a GOPBA (Fig. 2, lane 4) . Like the virions, the isolated glycoprotein bound efficiently to the Binding of MV to the nonreduced but not to the reduced form of MCP. To analyze the importance of the protein conformation of MCP for the binding of MV, biotinylated HRT cell surface proteins were isolated with streptavidinagarose and subjected to SDS-PAGE under nonreducing and reducing (5% mercaptoethanol) conditions. Both MV (Fig.  3A) and J4/48 (Fig. 3B) recognized the nonreduced (lane 1) but not the reduced (lane 2) form of the 67-kDa protein. A faint staining of the reduced form in the Western blot was detected only when the exposure time was extended from 10 to 45 s (Fig. 3B, lane 2' ). Detection of biotinylated reduced and nonreduced MCP with streptavidin/POX showed that no degradation bad taken place in the reduced sample ( data not shown). The result from Fig. 3 indicates that disulfide bonds are critical for maintaining a conformation of MCP that is recognized by MV as weil as by the MAb.
Binding ofMV glycoprotein to MC:P from dil'erent celllines. To compare the binding of MV to MCP from different cells, three MAbs to MCP were used for immunoprecipitation of biotinylated surface MCP from three celllines (HRT, HeLa, and Vero). As shown in Fig. 4A , J4/48 used for the experiments described above precipitated MCP only from human cells, HRT and HeLa. MAb TRA2-10, known as an antibody specific for the SCR1 domain of MCP (1), showed the same reactivity pattem (Fig. 4B) . Vero cells were also. included because they are infected by MV more efficiently than HRT or HeLa cells (data not shown). The antiborlies mentioned above failed to detect a protein in the monkey cell line. However, immunoprecipitation with a third antibody, GB24, resulted in the precipitation of MCP from all three celllines (Fig. 4C) . This antibody is specific for the short consensus repeat (SCR) 3 and 4 region of MCP (1).
The three celllines appear to express different isoforms of MCP. On the surface of HRT cells, a 67-kDa proteinwas the major form and a 60-kDa protein was the minor form. On HeLa cells, two isoforms of about 55 and 65 kDa were expressed, the smaller form being more abundant than the larger one. On Vero cells, only a 60-kDa proteinwas detected. These restilts are similar to those of others analyzing human and primate cell lines ( 4, 23, 32) .
To determine whether there is a difference between the various MCP isoforms concerning the recognition by MV, a binding assay with the GB24 immunoprecipitates from HRT, HeLa, and Vero cells was performed. Nonbiotinylated cells were used for the immunoprecipitation, and biotinylated MV glycoproteins were used for the binding assay. Bound glycoprotein was detected with streptavidin/POX. As shown in tated by GB24 from both cells ( compare Fig. 4C and 5) . The binding to the less abundant 65-kDa isoform of HeLa cells is detectable after Ionger exposure times (not shown).
Dependence of MV binding on tbe glycosylation of MCP. To analyze the importance of the carbohydrate moieties of MCP for the binding by MV, the protein was immunoprecipitated with J4/48 and treated with different glycosidases. VCNA was used for the removal of sialic acids. N-linked oligosaccharides were released by incubation with N-glycosidase F. 0-linked oligosaccharides were cleaved by treatment with VCNA and 0-glycosidase ( neuraminidase was required because 0-glycosidase acts only on desialylated oligosaccharides ). After SOS-PAGE and blotting to nitrocellulose, the digested samples were analyzed in a binding assay with biotinylated MV glycoproteins (Fig. 6) . Analysis of the digested samples by West~rn blotting confirmed that MCP bad not been degraded dunng the enzyme treatment (not shown).
In the case of HeLa cells, the treatment of MCP with glycosidases led to a pronounced decrease in size (Fig. 6) 
DISCUSSION
In this study, using in vitro binding assays, we have demonstrated the direct binding of MV and MV glycoproteins to MCP (CD46). This membrane glycoprotein widely distributed throughout human tissue, normally binds complement factors (C3b and C4b), and protects the cell from complementmediated darnage (21, 28) . The MCP gene is transcribed into multiple altematively spliced mRNAs coding for two groups of MCP isoforms with molecular masses of about 50 to 58 kDa and 59 to 68 kDa (29) . The differences in molecular mass are mainly due to different 0 glycosylation. 0-linked oligosaccharides are attached to membrane-proximal domains of MCP that are designated STPs, because they are enriched in serines, threonines, and prolines. Alternative splicing affects the number of STP regions ( one, two, or three) and concomitantly the number of 0-linked oligosaccharides. The three celllines used in this study express different MCP isoforms in different quantities. MV was found to bind to all of them. The HeLa MCP seemed to be recognized with lower efficiency than the other MCPs. The weak binding appears tobe due to the high extent of sialylation of HeLa MCP, because the removal of sialic acids improved the recognition of this protein by MV. We do not know whether the detrimelital effect of sialic acid is due to steric hindrance or due to the negative charge of this acidic sugar. Enzymatic release of the 0-linked oligosaccharides did not diminish virus binding. Therefore, the STP domains including the 0-glycans appear not to be required for the recognition of MCP by MV. This finding is substantiated by the finding that the four primary isoforms of MCP all support MV infection (22) .
The receptor determinant is more likely located at the N terminus of the ectodomain which is composed of four repeating units designated SCR 1 to 4. These domains contain three N-linked oligosaccharides (on SCRs 1, 2, and 4) and are responsible for the binding of complement factors C3b and C4b as weil as for the cofactor activity of MCP (1). Specifically, SCRs 3 and 4 are required for C3b binding and SCRs 2 to 4 are required for C4b binding, while SCR 2 may play a special role in cofactor activity (21) . MV is able tö recognize both human and simian MCP; i.e., its binding characteristics are similar to those of MAb GB24, which recognizes an epitope in the SCR 3 and 4 domain. Future work is needed to determine whether this domain also contains the receptor deterrninant on MCP for attachment of MV.
In contrast to 0 glycosylation, N-glycans appear to play an important role in the binding of MV to MCP. Release of N-linked oligosaccharides from MCP by treatment with Nglycosidase F abolished the recognition by MV. The importance of N-linked carbohydrates bad been suggested by a previous study. Following inactivation of receptors by protease treatment, regeneration of receptors was prevented in the presence of tuncamycin, an inhibitor of N glycosylation (26) . However, these authors have not shown whether the Iack of N-glycans directly affects the binding of MV or whether MCP lacking Asn-linked oligosaccharides is not transported to the cell surface or proteolytically degraded. Our results suggest that N glycosylation has a direct effect on the binding of MV to MCP. It is unlikely that the oligosaccharides themselves constitute the receptor determinant, because this would require a unique carbohydrate structure present only on MCP. However, the N-glycans may be part of the receptor determinant. Another possibility is that MV recognizes a conforrnational protein domain that is maintained only in the presence of N-linked oligosaccharides. Carbohydrates are known to affect the conformation of glycoproteins. In the case of MCP, Iack of the three N-linked oligosaccharides is not expected to have a dramatic effect, because J4/48 interacted very efficiently with N-glycosidase F-treated MCP. This antibody recognizes a conformational epitope, as shown by its poor reactivity with the reduced form of MCP. MV also failed to recognize MCP after cleavage of the disulfides bonds, indicating that the receptor deterrninant on MCP is conformation dependent. Thus, our data indicate that MV binds to a conformational epitope of MCP that requires the presence of N-linked oligosaccharides.
Our results are consistent with MCP constituting the primary attachment site for MV on the cell surface. At present we do not know the relationship between this virus receptor and moesin, another cellular protein involved in the initial stage of an MV infection. Among surface-biotinylated cellular proteins, MV was able to recognize only MCP, not a 75-kDa protein.
The failure to detect binding to moesin does not exclude a direct interaction between MV and this protein. It may be explained by the poor biotinylation of moesin or by the low amount present on the cell surface. Binding assays with isolated protein are required to demoostrate the direct binding of MV to moesin. As MAbs to both MCP and moesin inhibit infection by MV (12, 26) , it is unlikely that the two proteins function as alternative receptors. Our results favor a role for MCP as the primary attachment site for MV. It is conceivable that moesin plays a role in a postadsorption step. Altematively, MCP and moesin may interact with each other and form a complex that represents the actual receptor for MV. Future work is needed to determine the relationship between MCP and moesin with respect to an MV infection.
